As we continue to receive inquiries about potential Actos lawsuits from patients who allege long-term use of the drug caused their bladder cancer, we are pleased to see this litigation moving forward,
New York, New York (PRWEB) June 02, 2013
Court documents indicate that more than 1,500 Actos lawsuit claims alleging bladder cancer are now pending in a federal litigation underway in the U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports.
According to court records, an update on the number of Actos filings in the federal litigation was presented at a May 23rd status conference, which also addressed issues related to the status of discovery and the scheduling of bellwether trials in the litigation. Lawsuits filed in this proceeding allege the potential for long-term use of Actos, a type 2 diabetes drug manufactured by Takeda Pharmaceuticals, to cause or worsen bladder cancer. (In re: Actos Product Liability Litigation, MDL No. 2299)
“As we continue to receive inquiries about potential Actos lawsuits from patients who allege long-term use of the drug caused their bladder cancer, we are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free Actos bladder cancer lawsuit evaluations to patients who developed bladder cancer after using the medication for an extended period of time.
Actos Bladder Cancer Lawsuit Allegations
The federal multidistrict litigation for Actos bladder cancer lawsuits was created in the U.S. District Court, Western District of Louisiana in December 2011, after the U.S. Food and Drug Administration issued an alert warning the public that long-term use of the medication may increase a patient’s risk for developing bladder cancer.* There are now 1,500 cases pending in in the Western District of Louisiana, where the proceeding continues to move forward. According to court documents, the next status conference in the litigation has been scheduled for June 20, 2013. Court records further indicate the first bellwether trials for the Actos bladder cancer litigation have been scheduled as well, with the first trial is slated to begin on January 27, 2014, with the second to follow on April 14, 2014.
In addition to the federal litigation, Bloomberg.com reported on May 1st that claims filed over the medication used to control blood-sugar levels in type 2 diabetes patients are pending in state litigations in Illinois and California.**
Patients who took Actos and developed bladder cancer after long-term use of the drug may be eligible to seek compensation for medical bills, lost wages, pain and suffering and other damages. Learn more about how to file an Actos lawsuit by visiting Bernstein Liebhard LLP’s website or by calling one of the Firm’s Actos lawyers at 800-511-5092.
*FDA, June 15, 2011; fda.gov/drugs/drugsafety/ucm259150.htm
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP